Glaucoma is a disease managed over years, not episodes. Patients require visual field testing every six to twelve months, IOP measurements at every visit, optic nerve imaging on regular intervals, and medication regimens that must be actively supported to achieve adequate adherence. The administrative architecture to support that longitudinal care model — scheduling recurring test series, tracking test completion across time, documenting IOP trends, running adherence outreach, and pursuing prior authorizations for escalating treatment steps — is substantial and often poorly staffed. Virtual assistants purpose-built for glaucoma practice workflows are changing that equation.
Visual Field Test Series: Scheduling and Completion Tracking
Standard-of-care glaucoma management calls for automated visual field testing (Humphrey Field Analyzer or equivalent) at intervals determined by disease severity and stability — typically every six to twelve months for stable patients, more frequently for those with progressive or advanced disease. According to the American Glaucoma Society (AGS) preferred practice patterns, two to three reliable visual field tests per year are often needed to confirm progression with statistical confidence.
Maintaining that testing frequency across a panel of hundreds of glaucoma patients requires a proactive scheduling system that most practices do not have the staff to operate consistently. Virtual assistants manage glaucoma visual field scheduling by maintaining a testing calendar for each patient, sending scheduling outreach at the correct interval, booking appointments before the patient's next follow-up visit, and tracking which patients have completed their scheduled series versus which are overdue.
Practices that implement VA-managed visual field scheduling series report a 30–50% reduction in patients who arrive at their glaucoma follow-up without a recent field on record — a gap that forces reactive same-day testing, disrupts the clinic schedule, and delays the physician's ability to assess progression.
IOP Data Tracking and Trend Documentation
Intraocular pressure measurement is documented at nearly every glaucoma encounter, but the real clinical value lies in the longitudinal trend. Physicians need to know whether a patient's pressure has been consistently controlled over six visits or whether recent readings represent a departure from their established baseline. Most EMR systems capture individual IOP readings but do not automatically surface trend summaries in a format useful for rapid clinical review.
VAs trained in glaucoma practice operations maintain supplemental IOP tracking logs — typically in a structured spreadsheet or EMR note template — that display each patient's last six to twelve IOP readings by date, eye, and medication regimen at the time of measurement. Updated before each appointment, these logs give physicians a one-glance trend view that accelerates clinical decision-making during busy clinic sessions. When IOP readings outside the target range appear, VAs flag the patient record for priority review.
Selective Laser Trabeculoplasty Prior Authorization and Step Therapy
Selective laser trabeculoplasty (SLT) is increasingly used as a first-line or adjunctive treatment for open-angle glaucoma, with strong evidence supporting its efficacy and safety profile. However, many commercial payers require step therapy documentation before approving SLT — specifically, evidence that the patient has tried and failed (or is intolerant to) one or more topical IOP-lowering medications.
The prior authorization process for SLT requires compiling a treatment history that demonstrates appropriate pharmacotherapy trials, documenting the clinical rationale for procedural intervention, and submitting the package through the payer's authorization portal within the required window before the procedure date. For glaucoma practices performing SLT regularly, this documentation burden compounds quickly.
Virtual assistants manage the SLT authorization workflow end-to-end: building the medication history summary from EMR records, preparing the clinical justification narrative with physician input, submitting the authorization, tracking approval status, and scheduling the procedure only after confirmation is received. Denials are escalated to physician peer-to-peer review without delay.
Medication Adherence Outreach: A Glaucoma-Specific Imperative
Glaucoma medication non-adherence is a well-documented clinical problem. A 2022 Ophthalmology journal meta-analysis found that approximately 25–35% of glaucoma patients show suboptimal adherence to prescribed topical therapy, and poor adherence is directly associated with faster visual field progression. In the absence of structured outreach, non-adherence often goes undetected until it manifests as IOP elevation or field loss at the next scheduled visit.
VAs assigned to medication adherence programs execute proactive outreach between appointments — typically at 30 and 60 days post-prescription for new medications, and at regular intervals for established regimens. Outreach scripts address medication technique, side effect management, refill coordination, and the importance of consistent drop use. Patients who report difficulty or express intent to stop a medication are flagged for physician callback.
These structured adherence programs are particularly valuable for high-risk patients: those with advanced glaucoma, a history of prior progression, or documented adherence challenges. VAs can maintain priority adherence lists and customize outreach frequency for these segments without requiring physician or MA time.
Building a Sustainable Glaucoma Practice Admin Model
A glaucoma specialist seeing 20–25 patients per day across a full clinic schedule cannot simultaneously manage the longitudinal scheduling, data tracking, authorization, and adherence functions that protect those patients' vision. Offloading these functions to a trained VA at $1,200–$2,200 per month is not a cost-cutting measure — it is a care quality investment. For glaucoma practices looking to operationalize these capabilities, Stealth Agents provides VAs with the specialty background to handle glaucoma administrative workflows from their first day.
Sources
- American Glaucoma Society (AGS), Preferred Practice Patterns for Glaucoma Management, 2023
- Ophthalmology (journal), Meta-analysis of Glaucoma Medication Adherence, 2022
- American Academy of Ophthalmology, Glaucoma Preferred Practice Patterns, 2020